Diaceutics and Experian have partnered to integrate real-time diagnostic data into pharmaceutical marketing workflows, enabling targeted engagement with clinicians during critical treatment decision moments. This collaboration aims to enhance the precision of healthcare marketing by shifting focus from historical data to real-time clinical insights, allowing for more effective and timely campaigns.
The partnership between Diaceutics and Experian offers a significant advancement for pharmaceutical marketers by integrating real-time diagnostic data into marketing workflows. This allows for precise clinician targeting at critical treatment decision moments, as around 70% of therapy decisions happen upon receiving lab results. For someone focused on healthtech and precision medicine, this presents an opportunity to leverage data-driven marketing to influence clinical decision-making processes effectively, potentially boosting the impact of pharmaceutical campaigns.